Acrylic Acid

Acrylic Acid

SCHEMBL2215810

C=CC(=O)O.C=CCOC(=O)c1ccc(C(=O)OCC=C)c(C(=O)OCC=C)c1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.58
ALDH1A1 P00352 4/20 0.48
TSHR P16473 3/20 0.48
HSD17B10 Q99714 2/20 0.48
SNCA P37840 1/20 0.47
MAPK1 P28482 2/20 0.43
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RHOA P61586 1/20 0.39
GAA P10253 2/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
APP P05067 1/20 0.35
TP53 P04637 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29376657 0.94 CYP3A4 (0.66) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL48751 0.94 CYP3A4 (0.66) CYP3A4ALDH1A1TSHRHSD17B10SNCA
Benzene SCHEMBL9554798 0.91 CYP3A4 (0.63) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL5366925 0.88 CYP3A4 (0.62) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL10072249 0.87 CYP3A4 (0.57) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL10072072 0.87 CYP3A4 (0.57) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL9471198 0.85 CYP3A4 (0.51) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL7195876 0.84 CYP3A4 (0.53) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL30843873 0.84 CYP3A4 (0.50) CYP3A4ALDH1A1TSHRHSD17B10SNCA
SCHEMBL10965072 0.84 CYP3A4 (0.57) CYP3A4ALDH1A1TSHRHSD17B10SNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9631056-B2 Core-first nanoparticle formation process, nanoparticle, and composition BRIDGESTONE CORPORATION (JP) 2017-04-25 US disclosed
US-20160039964-A1 WELL DEFINED, HIGHLY CROSSLINKED NANOPARTICLES AND METHOD FOR MAKING SAME BRIDGESTONE CORPORATION (JP) 2016-02-11 US disclosed
US-9115222-B2 Well defined, highly crosslinked nanoparticles and method for making same BRIDGESTONE CORPORATION (JP) 2015-08-25 US disclosed
EP-2370349-B1 CORE-FIRST NANOPARTICLE FORMATION PROCESS, NANOPARTICLE, AND COMPOSITION BRIDGESTONE CORP (JP) 2014-10-29 EP disclosed
US-8846819-B2 Core-first nanoparticle formation process, nanoparticle, and composition BRIDGESTONE CORPORATION (JP) 2014-09-30 US disclosed
US-20120132346-A1 Core-First Nanoparticle Formation Process, Nanoparticle, And Composition BRIDGESTONE CORPORATION (JP) 2012-05-31 US disclosed
EP-2370349-A2 CORE-FIRST NANOPARTICLE FORMATION PROCESS, NANOPARTICLE, AND COMPOSITION Bridgestone Corporation (JP) 2011-10-05 EP disclosed
US-20110236686-A1 Well Defined, Highly Crosslinked Nanoparticles And Method For Making Same BRIDGESTONE CORPORATION (JP) 2011-09-29 US disclosed
US-20110172364-A1 Charged Nanoparticles And Method Of Controlling Charge YAOHONG CHEN 2011-07-14 US disclosed
WO-2010078320-A2 CORE-FIRST NANOPARTICLE FORMATION PROCESS, NANOPARTICLE, AND COMPOSITION BRIDGESTONE CORPORATION (JP) 2010-07-08 WO disclosed